Mankind Pharma acquires Bharat Serums from Advent International for ₹13,630 crore. Learn More
Company
We are driven by three core values of quality, affordability and accessibility.
R&D & Innovation
With 6 cutting-edge R&D facilities, we pioneer breakthroughs like Dydragesterone in pharmaceutical excellence.
Safety & Sustainability
We have adopted policies aimed at complying with legislative requirements and ensuring the safety of our employees and the personnel working at our facilities or under our management.
International
Committed towards a healthier and happier world, we strive to provide accessible and affordable healthcare to all sections of the society.
Investor Center
Mankind Pharma Ltd
NSE: MANKIND
-
-
Careers
Mankind Pharma is not just a workplace; it's a frontier of innovation. Join us in leveraging science to shape a healthier Bharat.
Shop
Discover more of Mankind
Close
Annual Report
Investor Centre
Annual Report
REVENUE
₹ 10,335 Cr
EBITDA
₹ 2,550 Cr
PAT
₹ 1,942 Cr
download FY 23-24 report
Annual Reports
FY2023-24
FY2022-23
FY2021-22
FY2020-21
FY2019-20

Loading...

Loading...

Loading...

Loading...

Loading...

Financials of Subsidiaries
FY2023-24
FY2022-23

Loading...

Loading...

Know more about us
Home
About Us
R&D
Quality